The Synergy of Dual Agonism What sets Tirzepatide apart in current research is its ability to mimic two endogenous hormones rather than just one
The broader pattern of GLP-1 drugs reducing addictive and compulsive behavior has shown up across multiple datasets, including a 606,000-veteran cohort published in BMJ earlier this year showing meaningful reductions in alcohol, nicotine, and opioid use disorder rates in GLP-1 users
The weekly injection schedule printed on your prescription label looks rigid, almost sacred, but the pharmacology behind tirzepatide tells a more flexible story than most people realize
120 calories, 6g protein
Safety & Candidacy Tirzepatide is FDA-approved for adults with a BMI of 30 or higher, or 27+ with at least one weight-related condition such as hypertension, type 2 diabetes, dyslipidemia, or cardiovascular disease
Reduction in Inflammation Obesity-related inflammation contributes to airway obstruction and increased severity of sleep apnea